2,855
edits
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
The provision of a supportive therapeutic setting prior to, during, and following drug administration is now the standard of care in the majority of uses of psychedelic medications for the treatment of psychiatric disorders. To fill this requirement, a variety of psychedelic-assisted therapy (PAT) models and certifications (CPAT) have been developed to ensure the guiding clinician is sufficiently competent. These include: | The provision of a supportive therapeutic setting prior to, during, and following drug administration is now the standard of care in the majority of uses of psychedelic medications for the treatment of psychiatric disorders. To fill this requirement, a variety of psychedelic-assisted therapy (PAT) models and certifications (CPAT) have been developed to ensure the [[Guided Psychedelic Therapy|guiding clinician]] is sufficiently competent. These include: | ||
* '''Embark'''<ref>'''Models of Psychedelic-Assisted Psychotherapy''': A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. William Brennan and Alexander B. Belser. Cybin, Inc., Toronto, ON, Canada and Fordham University, New York City, NY, United States. Front. Psychol., 02 June 2022 <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref> - Canadian / US proprietary Cybin ltd training system released in June 2022. | * '''Embark'''<ref>'''Models of Psychedelic-Assisted Psychotherapy''': A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. William Brennan and Alexander B. Belser. Cybin, Inc., Toronto, ON, Canada and Fordham University, New York City, NY, United States. Front. Psychol., 02 June 2022 <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref> - Canadian / US proprietary Cybin ltd training system released in June 2022. |